Endovascular Aneurysm Repair (EVAR) Market Market Size to Hit USD 5.6 Billion by 2035

Market Overview and Definition

The global Endovascular Aneurysm Repair (EVAR) market size was valued at approximately USD 2.8 billion in 2025 and is projected to reach USD 5.6 billion by 2035, growing at a CAGR of 7.2% during the forecast period.

Endovascular Aneurysm Repair represents a critical component of modern medical procedures, designed specifically to treat aneurysms through minimally invasive techniques. The market encompasses a range of products, services, and solutions including stent graft systems and catheter delivery systems. The ecosystem involves healthcare providers, medical device manufacturers, and regulatory bodies, all cooperating to enhance clinical outcomes and patient safety. This market plays a pivotal role in reducing procedural complications and improving the quality of life for patients suffering from aneurysms.

Over the years, the industry has evolved from rudimentary surgical techniques to sophisticated, regulated procedures with increased efficacy and reduced recovery times. The maturity of the EVAR market is marked by a transformation in technology and enhanced strategic importance, leading to an optimistic market outlook.

Segment Category Market Significance Analysis

By Product Type

With an estimated market share of 40%, this segment represents one of the major contributors to industry revenue. The segment is bolstered by the demand for advanced catheter systems that facilitate seamless endovascular access, driven by technological advancements and their widespread application in clinical settings.

Primary Segment Contribution

Stent Graft Systems – 55%: Dominating this category, these systems are crucial for delivering effective treatment, with proven success in reducing recovery times and complications.
Catheter Delivery Systems – 45%: These systems are essential for accurately positioning stent grafts, gaining traction due to enhanced precision and reduced invasiveness.

By Application

This segment accounts for approximately 35% of the overall market, driven by diverse clinical applications controlling its application scope and investment priorities in specific healthcare areas.

Primary Segment Contribution

Abdominal Aortic Aneurysms – 65%: This segment experiences greater demand due to the prevalence of abdominal aneurysms and the effectiveness of EVAR techniques for treatment.
Thoracic Aortic Aneurysms – 35%: Continues to grow as innovation in medical devices and evolving surgical techniques create opportunities for improved patient outcomes.

By Technology

Holding a 15% market share, this segmentation underscores the impact of technology in advancing treatment methodologies and improving the reliability of procedures.

Primary Segment Contribution

Traditional EVAR – 60%: This technology remains prevalent for its established reliability in clinical use.
Branched and Fenestrated EVAR – 40%: Accounts for a significant part due to customized solutions for complex aneurysms offering improved results.

By End-use Industry

Making up 10% of the market, this category derives significance from its ability to cater to varied healthcare settings and operational needs effectively.

Primary Segment Contribution

Hospitals – 70%: Leading demand mainly driven by institutional budgets and integrated healthcare services.
Specialty Clinics – 30%: Show consistent growth due to specialized care and advanced clinical techniques implemented within these settings.

Drivers Impact Analysis

Impact Factor	(~) % Impact on CAGR Forecast	Geographic Relevance	Impact Timeline
Advanced Medical Technologies	+1.2%	Global	Medium to Long Term
Aging Population	+1.1%	North America, Europe	Long Term
Increased Healthcare Expenditure	+0.8%	Asia Pacific	Medium Term
Rising Cases of Cardiovascular Diseases	+0.9%	Global	Long Term
Regulatory Support for Minimally Invasive Techniques	+1.0%	North America	Short to Medium Term
Hospital Infrastructure Development	+0.7%	Asia Pacific, Middle East & Africa	Medium to Long Term
Increasing Awareness of EVAR Benefits	+0.5%	Latin America	Short Term

Drivers will enhance market adoption through improved healthcare technologies and awareness initiatives, gaining significant traction across diverse geographies within the medium to long-term period.

Market Growth Analysis and Industry Transformation

The Endovascular Aneurysm Repair market has historically experienced steady growth driven by the demand for less invasive aneurysm treatments. Currently, the market is in a phase of accelerated expansion, as healthcare providers adopt advanced technology, and manufacturers invest in scalable solutions. Moving forward, the market looks set to sustain growth due to rising healthcare expenditures and an aging population.

Demand dynamics are robust, with an increased emphasis on advanced clinical methods and the adoption of cutting-edge medical technologies. As identified in primary interviews with key stakeholders, investments in infrastructure and capabilities are reportedly increasing, with a focus on CAPEX for technological innovations and geographic expansion.

Growth drivers such as technological innovation and regulatory support will continue to encourage premiumization, while challenges such as cost barriers and competitive pressure may restrict market entry for new players.

Segmental Market Analysis

The leading segment within the EVAR market is the Stent Graft Systems, primarily due to their essential role in treatment and effectiveness in delivering better clinical outcomes. Catheter Delivery Systems, although vital, command a slightly lower market share tied to the dependent nature of their application.

Meanwhile, Thoracic Aortic Aneurysms is projected to be the fastest-growing segment, driven by ongoing innovations and increased healthcare investments specific to this application. Emerging segments such as Branched and Fenestrated EVAR hold potential for growth due to their ability to address complex aneurysms.

Technology, Innovation, and Future Transformation

The EVAR market is poised for significant transformation driven by technological innovations, such as the development of more versatile stent graft designs and enhanced imaging technologies that improve procedural accuracy. With substantial R&D investments, the innovation pipeline is rich with product developments and ongoing patent activity. Digital transformation through AI and automation is likely to reshape business models, improve pricing strategies, and hone competitive advantages.

Value Chain, Supply Chain, Cost and Profitability Analysis

Upstream, supply chains are characterized by concentrated suppliers providing essential raw materials, with pricing impacting downstream costs. Manufacturing processes are increasingly tech-intensive, leveraging cutting-edge technology for improved capacity utilization. Primary research notes that profitability depends heavily on execution across the value chain, emphasizing cost-effective distribution and sustainability-driven investment attractiveness.

Regulatory, Policy and Industry Standards Analysis

The regulatory landscape is conducive to market growth, with policies supporting minimally invasive procedures providing a competitive edge. Compliance with international standards is crucial, as reflected in increased clinical and regulatory scrutiny. Effectively navigating this environment can reduce operating costs and streamline market entry.

Regional Market Insights

In North America, the EVAR market benefits from mature healthcare infrastructure and continued investment, holding the largest market share. Europe exhibits high regulatory and sustainability standards, fostering strong adoption trends. Asia Pacific presents a promising growth trajectory fueled by manufacturing advantages and rising healthcare investments.

Latin America offers emerging opportunities powered by increased healthcare awareness. Meanwhile, the Middle East & Africa region is witnessing gradual market development driven by hospital infrastructure expansion and investment facilitation.

Competitive Landscape and Strategic Analysis

The market structure remains moderately consolidated, with leading companies such as Medtronic and Cook Medical dominating revenue contributions through comprehensive product portfolios and expansive geographic presence. Strategic collaborations and M&A activities underscore their competitive positioning, as evidenced by the ongoing focus on innovation and market expansion. The report evaluates competitive benchmarking, company positioning matrix, and market share analysis.

Consulting Framework Insights

The EVAR market is analyzed using Porter's Five Forces and PESTLE frameworks, presenting a favorable market attractiveness for new entrants and existing shareholders. Market attractiveness is elevated by strong regulatory support and technological advancements, while competitive pressures present both opportunities and challenges.

Analyst View

Over the next 5–10 years, the Endovascular Aneurysm Repair market is poised for substantial growth driven by advances in technology, geographic expansion, and increased healthcare awareness. Companies are advised to prioritize segments such as Thoracic Aortic Aneurysms and regions like Asia Pacific, given their growth potential. Innovation and regulatory compliance remain vital capabilities for future market leaders. Monitoring cost structures and navigating competitive challenges will also be critical for sustained success.

Detailed Market Segmentation & Sub-Segmentation

By Product Type
- Stent Graft Systems
  - Abdominal Stent Grafts
  - Thoracic Stent Grafts
- Catheter Delivery Systems
  - Balloon Catheters
  - Microcatheters
By Application
- Abdominal Aortic Aneurysms
  - Emergency Repair
  - Elective Repair
- Thoracic Aortic Aneurysms
  - Complex Aneurysm Repair
  - Standard Repair
By Technology
- Traditional EVAR
  - Open Technique
  - Laparoscopic Technique
- Branched and Fenestrated EVAR
  - Custom Devices
  - Pre-made Devices
By End-use Industry
- Hospitals
  - Public Hospitals
  - Private Hospitals
- Specialty Clinics
  - Cardiovascular Clinics
  - Other Specialty Clinics
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa